Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ...

The US Food and Drug Administration (FDA) has approved aprocitentan (Tryvio) to lower blood pressure, in combination with other antihypertensive agents, in adults with treatment-resistant hypertension ...

Managing hypertension isn't just about what you add to your plate; it’s about the hidden "sodium traps" and inflammatory ...

Please provide your email address to receive an email when new articles are posted on . A systemic sclerosis-related pulmonary hypertension diagnosis in the last 10 years vs. 10 years prior was linked ...

Please provide your email address to receive an email when new articles are posted on . Optometrists should screen all patients for hypertension and offer education on the topic. If the blood pressure ...

A gospel truth in ophthalmology has been that people of African ancestry are more likely to develop glaucoma, but a new study clouded the picture. The long-term cohort study has identified modifiable ...

Fatty Liver and High Blood Pressure: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with high blood pressure, or hypertension, but the cause-effect ...

Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...